Clarke K, King M, Prost A Psychosocial interventions for perinatal common mental disorders delivered by providers who are not mental health specialists in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2013 Oct;10(10):
Deuchar N New Joint Commissioning panel for mental health could help GPs to commission mental health services more effectively. Ment Health Today. 2011 Jun:9.
Edge D Perinatal Mental Health of Black and Minority Ethnic Women: A Review of Current Provision in England, Scotland and Wales. National Mental Health Development Unit. 2011.
Josefsson A, Berg G, Nordin C, Sydsjö G Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand. 2001 Mar;80(3):251-5.
O'Hara MW, Swain AM Rates and risk of postpartum depression - a meta-analysis. Int Rev Psychiatry, 1996; 8:37-54
Oates M Perinatal maternal mental health services. Recommendations for provision of services for childbearing women. London: Royal College of Psychiatrists. 2001
Ramchandani PG, Stein A, Evans J, O'Connor TG Paternal depression in the postnatal period and child development: a prospective population study. Obstetrical & gynaecological survey, 2005;60(12), 789-790
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
